First Premier Bank Gilead Sciences, Inc. Transaction History

First Premier Bank

$378 Million
Q1 2024

A detailed history of First Premier Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, First Premier Bank holds 9,505 shares of GILD stock, worth $633,888. This represents 0.18% of its overall portfolio holdings.

Number of Shares

9,505

Previous 9,635 1.35%

Holding current value

$633,888

Previous $780,000 10.77%

% of portfolio

0.18%

Previous 0.22%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$71.58 - $87.29 $9,305 - $11,347	-130 Reduced 1.35%	9,505 $696,000
Q3 2023 Oct 16, 2023	SELL	$73.94 - $80.67 $121,483 - $132,540	-1,643 Reduced 14.57%	9,635 $722,000
Q2 2023 Jul 13, 2023	SELL	$76.01 - $86.7 $38,005 - $43,350	-500 Reduced 4.25%	11,278 $868,000
Q1 2023 Apr 10, 2023	SELL	$77.31 - $88.08 $7,731 - $8,808	-100 Reduced 0.84%	11,778 $978,000
Q4 2022 Jan 17, 2023	SELL	$62.32 - $89.47 $335,593 - $481,795	-5,385 Reduced 31.19%	11,878 $1.02 Million

Q3 2022 Oct 20, 2022	BUY	$59.54 - $68.01 $23,220 - $26,523	390 Added 2.31%	17,263 $1.07 Million
Q2 2022 Jul 26, 2022	SELL	$57.72 - $65.01 $750 - $845	-13 Reduced 0.08%	16,873 $1.04 Million
Q1 2022 Apr 25, 2022	BUY	$57.92 - $72.58 $57,920 - $72,580	1,000 Added 6.29%	16,886 $1 Million
Q2 2021 Jul 14, 2021	SELL	$63.47 - $69.35 $151,249 - $165,261	-2,383 Reduced 13.04%	15,886 $1.09 Million
Q1 2021 Apr 12, 2021	BUY	$60.0 - $68.46 $93,240 - $106,386	1,554 Added 9.3%	18,269 $1.18 Million
Q4 2020 Jan 12, 2021	SELL	$56.65 - $64.55 $52,684 - $60,031	-930 Reduced 5.27%	16,715 $975,000
Q3 2020 Oct 06, 2020	BUY	$62.1 - $78.08 $31,050 - $39,040	500 Added 2.92%	17,645 $1.12 Million
Q2 2020 Jul 07, 2020	SELL	$72.34 - $84.0 $27,127 - $31,500	-375 Reduced 2.14%	17,145 $1.32 Million
Q1 2020 Apr 08, 2020	BUY	$62.63 - $80.22 $2,818 - $3,609	45 Added 0.26%	17,520 $1.31 Million
Q4 2019 Jan 10, 2020	SELL	$61.62 - $67.78 $254,613 - $280,066	-4,132 Reduced 19.12%	17,475 $1.14 Million
Q3 2019 Oct 10, 2019	SELL	$62.51 - $69.0 $26,879 - $29,670	-430 Reduced 1.95%	21,607 $1.37 Million
Q2 2019 Jul 09, 2019	SELL	$61.87 - $69.38 $12,374 - $13,876	-200 Reduced 0.9%	22,037 $1.49 Million
Q1 2019 Apr 04, 2019	BUY	$62.53 - $70.05 $937 - $1,050	15 Added 0.07%	22,237 $1.45 Million
Q4 2018 Jan 14, 2019	SELL	$60.54 - $79.0 $173,144 - $225,940	-2,860 Reduced 11.4%	22,222 $1.39 Million
Q3 2018 Oct 09, 2018	SELL	$71.28 - $78.92 $50,751 - $56,191	-712 Reduced 2.76%	25,082 $1.94 Million
Q2 2018 Jul 10, 2018	BUY	$64.88 - $75.68 $10,056 - $11,730	155 Added 0.6%	25,794 $1.83 Million
Q1 2018 Apr 09, 2018	SELL	$72.84 - $88.8 $20,905 - $25,485	-287 Reduced 1.11%	25,639 $1.93 Million
Q4 2017 Jan 11, 2018	BUY	$71.15 - $83.52 $190,824 - $224,000	2,682 Added 11.54%	25,926 $1.86 Million
Q3 2017 Oct 13, 2017	BUY	$72.11 - $85.47 $1.68 Million - $1.99 Million	23,244	23,244 $1.88 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Premier Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Premier Bank with notifications on news.

Account

First Premier Bank Gilead Sciences, Inc. Transaction History